We are delighted to announce that our latest whitepaper, in collaboration with Back Bay Life Science Advisors: 'Microbiome Medicinal Products: Concept to Commercial', is now available to read and download. This whitepaper delves into the dynamic field of live biotherapeutic drug development, which over the last decade has emerged from an area of intriguing pre-clinical and clinical data to a space with multiple licensed medicines. This paper offers a comprehensive analysis of the current regulatory landscape, investment trends, and developmental strides in areas extending beyond gut…

Press release Macomics Launches Super Triathlon Challenge to Raise Funds for Prof. Jeffrey Pollard Memorial Fund Edinburgh and Cambridge, UK, 25 October 2023 – Macomics Ltd, a leader in macrophage drug discovery, is delighted to announce that it has launched the Macomics Hyper-Triathlon Challenge, in honour of its co-founder Prof. Jeffrey Pollard, who passed away earlier this year, to raise funds for the newly established Jeff Pollard’s memorial fund. The new charitable fund, managed by the University of Edinburgh where Prof. Pollard was Director of the MRC Centre for Reproductive Health,…

Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead program to identify SHP2 degraders.  SHP2 is a tyrosine-specific phosphatase implicated in human cancers and the objective is to develop potent bifunctional compounds with excellent ADME and PK properties for efficient degradation of SHP2. Through the collaboration, the teams have discovered unique hit compounds (profile: single-digit nM DC50 and approximately 100% Dmax) utilizing Sygnature Discovery’s innovative proprietary CHARMED technology platform. The CHARMED platform was developed by Sygnature…

Medicilon once again won the "Top 50 Chinese Pharmaceutical R&D" in 2022-2023 based on its comprehensive strength. The "Most Influential List of China's Pharmaceutical Industry" by the All-China Federation of Industry and Commerce (ACFIC), Pharmaceutical Chamber of Commerce has become one of the authoritative lists of Chinese pharmaceutical industry. The ACFIC invited first-class Chinese experts to form a selection team. The selection adheres to the principles of open collection, objective data, strict screening, and fair selection. United with a number of well…

Cambridge, UK: Following the resounding success of the inaugural edition of the tech Kickstarter Competition in Jan 2023, o2h technology (a business vertical of the o2h group) is excite to launch the second edition of the o2h tech kickstarter competition designed to support seed stage life science, greentech, and tech/AI companies with their MVP, web, mobile app design & development needs. The first edition of this competition received an overwhelming response. We had over 25 seed early-stage companies who applied, out of which we chose 3 final winners including …

Following the resounding success of its inaugural edition in Jan 2023, o2h technology (a business vertical of the o2h group) is excited to launch the second edition of the o2h tech kickstarter competition designed to support seed stage life science, greentech, and tech/AI companies with their MVP, web, mobile app design & development needs. The first edition of this competition received an overwhelming response. We had over 25 seed early-stage companies who applied, out of which we chose 3 final winners including RouteZero, a Greentech startup committed to decarbonising business travel,…

 Click here to view the September 2023 edition of The Meeting Place!

• Eva-Lotta Allan’s excellent track record of corporate, business development and operational experience strengthens industry-leading Board and Executive Leadership team • Maxion’s lead KnotBody® programme is progressing rapidly towards preclinical development with a first-in-class and best-in-class potential Cambridge, UK – 21 September 2023 – Today, Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its…

Unlock a 25% discount today on all OGM services with Source Genomics, limited time only. OGM is introducing a new dimension to genomic analysis, taking a high-resolution snapshot of genome structure in its entirety, including structural variants and large-scale re-arrangements. Researchers from all avenues of the genomic medicine field can anticipate OGM to play a key role in diagnosing genetic diseases more accurately, accelerating drug discovery by revealing target genes and pathways and uncovering novel genetic variations linked to complex conditions. While many industry and academic…

Anglia Ruskin University has been shortlisted for the University of the Year award in this year’s Times Higher Education (THE) Awards, widely known as the Oscars of the UK university sector. They are also shortlisted for the Outstanding Contribution to the Local Community award (for the creation of ARU Peterborough) and Outstanding Contribution to Equality, Diversity and Inclusion award (for our SHoKE project).  Visit THE University of the Year shortlist - ARU for more information and a short film showcasing their achievements can be viewed here: https://youtu.be/9ct3syztzsw.